Northwest Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Northwest Bank & Trust's BMY Position: Q4 2024 in Review
Northwest Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 0.14% in Q4 2024, buying an estimated $726 and bringing the position to 9,631 shares worth $570K. The position accounts for 0.42% of the portfolio, ranked #58.
Northwest Bank & Trust first reported a position in BMY in Q2 2023 and has held it in 6 quarters since. The position peaked at $649K in Q2 2023. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Northwest Bank & Trust held 9,631 shares of Bristol-Myers Squibb worth $570K as of Q4 2024.
- Northwest Bank & Trust bought 13 Bristol-Myers Squibb shares in Q4 2024, an estimated $726.
- Bristol-Myers Squibb made up 0.42% of Northwest Bank & Trust's portfolio in Q4 2024, its #58 holding.
- Northwest Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 6 quarters since.
- Northwest Bank & Trust's Bristol-Myers Squibb position peaked at $649K in Q2 2023.
- 2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.